Scholarlink

Introduction <p>This work aims to monitor the stability of composite descriptors of uncorrected distance (UCDVA), intermediate (UCIVA), and near (UCNVA) logMAR acuities after uneventful phacoemulsification and presbyopia correcting intra-ocularlenses (PCIOLs) implantation.</p> Methods <p>Patients implanted with AcrySof IQ PanOptix (group 1, <i>n</i> = 32), TECNIS Symfony (group 2, <i>n</i> = 35), TECNIS bifocal (group 3, <i>n</i> = 34), or TECNIS monofocal (comparative, group 4, <i>n</i> = 32) were followed up for 12 months. In each case, the errors in the composite descriptor of [I] UCDVA and UCNVA doublets (EDN = √[(UCDVA)<sup>2</sup> + (UCNVA)<sup>2</sup>]) and [II] UCDVA, UCIVA and UCNVA triplets (EDIN = √[(UCDVA)<sup>2</sup> + (UCIVA)<sup>2</sup> + (UCNVA)<sup>2</sup>]) were monitored for targeted postoperative uncorrected logMAR acuities of zero. EDN and EDIN values were subjected to 2D and 3D graphical treatments to identify the absolute changes (ΔEDN and ΔEDIN) occurring between 1&#xa0;week and 1&#xa0;month, 1 and 6&#xa0;months, and 6 and 12&#xa0;months.</p> Results <p>There were small changes in residual refractive errors, UCDVA, UCIVA, UCNVA, EDN, EDIN, ΔEDN, and ΔEDIN values within, or between, groups 1–3. In groups 1 to 4, respectively. (i) Between 1&#xa0;week and 1&#xa0;month postop, the mean (± SD, 95% CI) ΔEDN values were 0.03 (± 0.05, 0.01–0.05), 0.05 (± 0.08, 0.02–0.08), 0.04 (± 0.07, 0.02–0.06), 0.19 (± 0.14, 0.14–0.24) and the ΔEDIN values were 0.04 (± 0.06, 0.01–0.05), 0.06 (± 0.10, 0.03–0.09), 0.04 (± 0.08, 0.01–0.07), 0.23 (± 0.14, 0.18–0.28). Differences were significant (one-way ANOVA for ΔEDN,<i> F</i> = 20.65,<i> p</i> &lt; 0.001; for ΔEDIN,<i> F</i> = 25.03, <i>p</i> &lt; 0.001), but not after excluding group 4. (ii) Between 6 and 12&#xa0;months, postop ΔEDIN values &gt; 0.1 logMAR occurred in 3 (10%), 6 (17%), 4 (12%), and 1 (3%) of cases.</p> Conclusions <p>The changes in uncorrected distance, intermediate, and near visual acuities were small and remained relatively stable 1&#xa0;week following implantation with PCIOLs. Fewer than 20% of cases experienced a change in composite description of acuities &gt; 0.1 logMAR between 6 and 12&#xa0;months postop.</p> Trial Registration <p>ClinicalTrials.gov identifier: NCT07008768.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Comparing Clinical Outcomes of Various Presbyopia-Correcting Intraocular Lenses Using a Novel Composite Method for the Analysis and Reporting of Uncorrected Distance, Intermediate, and Near Visual Acuities

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年11月14日

查看全文
  • Mateja Jagić,
  • Maja Bohač,
  • Alma Bišćević,
  • Smiljka Popović Suić,
  • Sudi Patel

摘要

Introduction

This work aims to monitor the stability of composite descriptors of uncorrected distance (UCDVA), intermediate (UCIVA), and near (UCNVA) logMAR acuities after uneventful phacoemulsification and presbyopia correcting intra-ocularlenses (PCIOLs) implantation.

Methods

Patients implanted with AcrySof IQ PanOptix (group 1, n = 32), TECNIS Symfony (group 2, n = 35), TECNIS bifocal (group 3, n = 34), or TECNIS monofocal (comparative, group 4, n = 32) were followed up for 12 months. In each case, the errors in the composite descriptor of [I] UCDVA and UCNVA doublets (EDN = √[(UCDVA)2 + (UCNVA)2]) and [II] UCDVA, UCIVA and UCNVA triplets (EDIN = √[(UCDVA)2 + (UCIVA)2 + (UCNVA)2]) were monitored for targeted postoperative uncorrected logMAR acuities of zero. EDN and EDIN values were subjected to 2D and 3D graphical treatments to identify the absolute changes (ΔEDN and ΔEDIN) occurring between 1 week and 1 month, 1 and 6 months, and 6 and 12 months.

Results

There were small changes in residual refractive errors, UCDVA, UCIVA, UCNVA, EDN, EDIN, ΔEDN, and ΔEDIN values within, or between, groups 1–3. In groups 1 to 4, respectively. (i) Between 1 week and 1 month postop, the mean (± SD, 95% CI) ΔEDN values were 0.03 (± 0.05, 0.01–0.05), 0.05 (± 0.08, 0.02–0.08), 0.04 (± 0.07, 0.02–0.06), 0.19 (± 0.14, 0.14–0.24) and the ΔEDIN values were 0.04 (± 0.06, 0.01–0.05), 0.06 (± 0.10, 0.03–0.09), 0.04 (± 0.08, 0.01–0.07), 0.23 (± 0.14, 0.18–0.28). Differences were significant (one-way ANOVA for ΔEDN, F = 20.65, p < 0.001; for ΔEDIN, F = 25.03, p < 0.001), but not after excluding group 4. (ii) Between 6 and 12 months, postop ΔEDIN values > 0.1 logMAR occurred in 3 (10%), 6 (17%), 4 (12%), and 1 (3%) of cases.

Conclusions

The changes in uncorrected distance, intermediate, and near visual acuities were small and remained relatively stable 1 week following implantation with PCIOLs. Fewer than 20% of cases experienced a change in composite description of acuities > 0.1 logMAR between 6 and 12 months postop.

Trial Registration

ClinicalTrials.gov identifier: NCT07008768.